Enovis develops medical technology for orthopedics and recovery, spanning surgical implants and bracing, cold therapy, and rehabilitation devices. Its portfolio includes well-known brands such as DonJoy, Aircast, Exos, Compex, and Chattanooga, used by surgeons, clinics, and patients for mobility, sports medicine, and post-operative care. The company emphasizes clinically differentiated products aimed at measurable patient outcomes and streamlined clinical workflows.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 564.5 | — | -36.7 | — |
| Q3 2025 | 548.9 | — | -571.1 | — |
| Q4 2025 | 575.8 | — | -520.6 | — |
| Q1 2026 | 589.1 | — | -8.8 | — |
| Q2 2026 | 582.8 | 3.2% | -1.2 | — |
All markets — KeepWinning global stock screener
Other companies on NYSE: Cadre Holdings, Inc. (CDRE), Newsmax, Inc. (NMAX), Bowhead Specialty Holdings Inc. (BOW), Amprius Technologies, Inc. (AMPX), Ecovyst Inc. (ECVT), Walker & Dunlop, Inc. (WD)